C
Centessa Pharmaceuticals plc (CNTA)
NMS – Real Time Price. Currency in USD
40.50
0.00 (0.00%)
At close: Jun 23, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
40.50
0.00 (0.00%)
At close: Jun 23, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
Total debt $118.6M significantly exceeds cash reserves ($62.4M), raising financial stability concerns
Total current assets $348.7M exceed Total current liabilities $36.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-29.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$72.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 9.53 | 6.05 | 10 | |
| Quick ratio | 9.53 | 5.63 | 10 | |
| Debt to Equity | 0.24 | 0.30 | 8.0 | |
| Debt to Assets | 0.18 | 1.04 | 8.0 | |
| Interest coverage | -29.21 | -16.91 | 1.0 | |
| Weighted average score | 7.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 7M | N/A | 15M | N/A |
| Gross Profit | -131K | 6M | -942K | 14M | -944K |
| Operating Income | -210M | -172M | -201M | -208M | -257M |
| Net Income | -216M | -152M | -236M | -198M | -251M |
| EBITDA | -210M | -171M | -200M | -207M | -256M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -7.52 | 1.0 |
| Next quarter | N/A | -5.23 | 1.0 |
| Current year | -100 | -17.93 | 1.0 |
| Next year | N/A | -7.4 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -19.73 | 3.7 | -29.27 | 4.0 |
| Y/Y | -99.99 | -201.52 | -94.99 | -25.46 | 1.0 |
| 3y average | 632.67 | -3.2 | 10.47 | -1.68 | 4.8 |
| 5y average | 779.2 | -2379.76 | 21.46 | 189.22 | 7.8 |
| Weighted average score | 4.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |